Innate-like B-1a cells provide a first line of defense against pathogens, yet little is known about their transcriptional control. Here we identified an essential role for the transcription factor Bhlhe41, with a lesser contribution by Bhlhe40, in controlling B-1a cell differentiation. Bhlhe41 −/− Bhlhe40 −/− B-1a cells were present at much lower abundance than were their wild-type counterparts. Mutant B-1a cells exhibited an abnormal cell-surface phenotype and altered B cell receptor (BCR) repertoire exemplified by loss of the phosphatidylcholine-specific V H 12V κ 4 BCR. Expression of a pre-rearranged V H 12V κ 4 BCR failed to 'rescue' the mutant phenotype and revealed enhanced proliferation accompanied by increased cell death. Bhlhe41 directly repressed the expression of cell-cycle regulators and inhibitors of BCR signaling while enabling pro-survival cytokine signaling. Thus, Bhlhe41 controls the development, BCR repertoire and self-renewal of B-1a cells.
B-1 cells are innate-like B lymphocytes 1 that provide a first line of defense against pathogens and contribute to tissue homeostasis 2, 3 . They populate the peritoneal and pleural cavities and their associated fat tissue, as well as the spleen. Plasma cells derived from B-1 cells are the main source of antibodies of the immunoglobulin M (IgM) class, which are present in an unchallenged organism and are known as 'natural antibodies' 1 . B-1 cells can be distinguished from conventional B cells (B-2 cells) by their characteristic B220 lo CD19 + CD23 − CD43 + phenotype 2, 3 . The main subset of B-1 cells (B-1a cells) express the surface marker CD5, while the smaller CD5 − fraction represents B-1b cells.
B-1a cells are autoreactive and require a strong B cell receptor (BCR) signal for their differentiation 4 . Consequently, the differentiation of B-1a cells is impaired by mutations that attenuate BCR signaling or its costimulatory pathways 5 , whereas the loss of negative regulators of BCR signaling results in an expanded B-1a cell compartment 6, 7 . B-1a cells have a restricted BCR repertoire 2, 3 , which includes BCR specificities that recognize self carbohydrates and lipids 8 . Notably, a substantial fraction of the mouse peritoneal B-1a cells express the V H 12V κ 4 or V H 11V κ 14 (V κ 9) BCR, both of which recognize phosphatidylcholine (PtC) 9 present in plasma membranes of host cells and in some pathogenic bacteria 10 .
The first wave of B-1 cell development takes place during fetal and neonatal life and largely contributes to the adult B-1 cell compartment, as B-1 cells can self-renew throughout the lifetime of the organism 3, 11, 12 . In contrast, conventional follicular (FO) and marginal-zone (MZ) B-2 cells are constantly replenished by differentiation from hematopoietic stem cells (HSCs) in the bone marrow. Adult HSCs also contribute to B-1 cell differentiation [13] [14] [15] , although to a lesser extent than do fetal and neonatal HSCs 12 . The development of B-1 cells is still poorly understood and can be explained by two models. According to the 'lineage model' , B-1 and B-2 cells develop along distinct B cell lineages before BCR expression 3, 16 . This model is supported by the identification of a B-1-cell-specified progenitor cell population (Lin − CD93 + CD19 + B220 neg-lo ) that 'preferentially ' gives rise to B-1 cells 17, 18 . The 'selection model' proposes that the B-1a-cellfate 'decision' occurs after IgM expression by antigen-driven selection of a B-1a-cell-specific BCR 4, [19] [20] [21] .
Due to their unique physiological properties, innate-like B-1 cells are probably controlled by a transcriptional program that differs from that of B-2 cells. Indeed, the transcription factor Arid3a has been shown to act downstream of the microRNA-binding protein Lin28b and microRNA Let7 in a pathway that controls B-1 cell development 22, 23 . Moreover, loss of the pan-B cell regulators Oct2 (ref. 24) or IκBNS 25 affects the generation of B-1 cells more severely than the development of B-2 cells. However, the current understanding of the transcriptional network that controls the identity and function of B-1 cells is still rudimentary.
Here we found that B-1a cells depended on the basic-helixloop-helix transcription factors Bhlhe41 (also known as Dec2 or Sharp1) and Bhlhe40 (also known as Dec1, Sharp2 or Stra13), which are known to regulate different physiological processes in non-immune cells 26, 27 and to control immune responses in T cells [28] [29] [30] . Bhlhe41 exhibited high expression only in B-1 cells, whereas its closest homolog, Bhlhe40, had low and broad expression in the B lymphoid lineage. The number of B-1a cells was considerably lower in Bhlhe41 −/− mice than in wild-type mice, and this phenotype was more severe in Bhlhe41 −/− Bhlhe40 −/− double-knockout (DKO) mice. Detailed analysis of the DKO B-1a cells demonstrated a major role for Bhlhe41, with a lesser contribution by Bhlhe40, in the control of multiple aspects of B-1a cell biology, including their development, life-long self-renewal, unique cell-surface phenotype and restricted BCR repertoire.
RESULTS

B-1-cell-specific expression of Bhlhe41
By analyzing the differences between mouse splenic B-1a cells and FO B cells in their gene expression, we identified Bhlhe41 as a gene with a 23-fold higher expression in B-1a cells than in FO B cells 31 ( Supplementary Fig. 1a ). Within the hematopoietic system, Bhlhe41 exhibited high expression only in B-1a and B-1b lymphocytes, lung macrophages and microglia 32 (Supplementary Fig. 1b ). During B cell development, Bhlhe41 had low expression in pre-B cells, immature B cells and plasma cells of the bone marrow and in transitional B cells of the spleen (Supplementary Fig. 1b,c) . As Bhlhe40 is a close homolog of Bhlhe41 and both transcription factors have often redundant functions 33, 34 , we also assessed Bhlhe40 expression. Bhlhe40 exhibited a broad pattern of low expression in B cells, in contrast to its high expression in myeloid cells, natural killer (NK) cells and T cells (Supplementary Fig. 1b,c) .
To analyze Bhlhe41 expression at the single-cell level, we generated a bacterial artificial chromosome transgenic mouse line expressing a reporter gene cassette encoding Cre recombinase, an internal ribosomal entry site and the human cell-surface receptor CD2, under the control of Bhlhe41 regulatory elements (Bhlhe41-Cre-hCD2). The hCD2 reporter had high expression in all B-1 cells (Fig. 1a) . Low hCD2 expression was detected on MZ B cells, plasma cells and transitional B cells in the spleen (Fig. 1a) . Pre-B cells and immature B cells in the bone marrow exhibited only very low hCD2 expression, while pro-B cells, FO B cells, T cells and NK cells were largely hCD2 − ( Fig. 1a and Supplementary Fig. 1d ). Bhlhe41, however, had higher expression in immature B cells of the fetal and neonatal liver than in their adult bone-marrow counterparts ( Supplementary Fig. 1b,e ), which correlates with the greater propensity of fetal and neonatal precursor cells to generate B-1 cells 3 .
Induction of Bhlhe41 in follicular B cells upon activation
As the transcriptional programs of innate-like lymphocytes and their activated conventional counterparts often overlap, we analyzed the expression of Bhlhe41 in data sets obtained by high-throughput RNAsequencing (RNA-seq) of lipopolysaccharide (LPS)-stimulated FO B cells 35 . Bhlhe41 expression was strongly induced upon stimulation with LPS, while Bhlhe40 was downregulated ( Supplementary  Fig. 1f ), as reported 36 . Stimulation of sorted FO B cells from Bhlhe41-Cre-hCD2 reporter mice with LPS, antibody to IgM (anti-IgM) plus interleukin 4 (IL-4), or antibody to the costimulatory receptor CD40 (anti-CD40) plus IL-4 furthermore revealed that the Bhlhe41 reporter was induced under all three conditions ( Supplementary Fig. 1g ). We therefore speculated that Bhlhe41 might be upregulated during B-1 cell development as a result of the self-reactivity of B-1 cells.
Dependence of B-1a cells on Bhlhe41
To investigate the role of Bhlhe41 in B lymphopoiesis, we compared the B cell developmental stages and mature B cell subsets in wild-type and Bhlhe41 −/− mice, as well as in Bhlhe40 −/− Bhlhe41 −/− (DKO) mice, since Bhlhe41 often functions redundantly with Bhlhe40 (refs. 33, 34) . B cell development in the fetal liver and bone marrow was unaffected ( Supplementary Fig. 2a-c) , and the numbers of splenic MZ and FO B cells were also unchanged in Bhlhe41 −/− and DKO mice relative to that in wild-type mice ( Fig. 1b and Supplementary Fig. 2d ). Moreover, the DKO B cells produced nitrophenyl-specific antibodies after immunization with nitrophenyl-keyhole limpet hemocyanin, similar to wild-type B cells (data not shown). We concluded, therefore, that neither B-2 cell development nor immune responses were grossly affected by the deficiency in Bhlhe41 and Bhlhe40.
Bhlhe41 −/− mice, however, had a much lower number of B-1a cells in the spleen and peritoneal cavity than wild-type mice had, and DKO mice showed a slight further reduction in the number of B-1a cells ( Fig. 1b-e ). In contrast, Bhlhe40 −/− mice had a frequency of B-1a cells similar to that of wild-type mice ( Supplementary  Fig. 2e ). The residual DKO B-1a cells exhibited an altered surface phenotype, as indicated by lower expression of CD5 and higher expression of the B cell-associated marker B220 ( Fig. 1c) . Although B-1b cells also had high expression of Bhlhe41 ( Fig. 1a and Supplementary Fig. 1b,c) , their number was not decreased in Bhlhe41 −/− or DKO mice ( Fig. 1c and Supplementary Fig. 2d ). Together these data identified an essential role for Bhlhe41 in the generation of B-1a cells, while Bhlhe40 contributed to this process to a lesser extent, consistent with its low expression in B-1a cells (Supplementary Fig. 1b,c) .
We next analyzed mixed-fetal-liver chimeras generated by transfer of a 1:1 mixture of fetal liver cells from wild-type (CD45.1 + ) and DKO (CD45.2 + ) mouse embryos (at day 14.5) into lethally irradiated immunodeficient Rag2 −/− mice. The wild-type-to-DKO ratio of pro-B cells, pre-B cells and B cells of the bone marrow, total splenic B-2 cells and peritoneal B-2 and B-1b cells closely reflected that of the Lin − Sca-1 + c-Kit + stem cell-progenitor cell compartment ( Fig. 1f,g) , which confirmed that Bhlhe41 and Bhlhe40 were dispensable for the development and homeostasis of B-2 cells. In contrast, B-1a cells of the chimeras originated predominantly from wild-type precursor cells ( Fig. 1f,g) . Similar results were obtained when bone marrow cells rather than fetal liver cells were used for generating the chimeras, although the competitive disadvantage of the bone marrow DKO cells was lower ( Supplementary Fig. 2f ), which indicated that the B-1a cells derived from fetal liver might have been more sensitive to the loss of Bhlhe41 and Bhlhe40 than were B-1a cells derived from bone marrow. Together these experiments identified Bhlhe41 and Bhlhe40 as cell-intrinsic regulators of the differentiation and/or homeostasis of B-1a cells.
Altered BCR repertoire of Bhlhe41 −/− Bhlhe40 −/− B-1a cells We next used RNA-seq analysis to compare the gene expression in DKO B-1a cells with that in wild-type B-1a cells. As shown by principal-component analysis, the DKO B-1a cells clustered closely with their wild-type counterparts, away from FO and MZ B cells ( Supplementary Fig. 3a ), which indicated that these cells largely maintained their B-1a cell identity. Unexpectedly, the most prominent group of differentially expressed genes encoded variable (V) segments of the immunoglobulin heavy and light chains ( Fig. 2a,b) , which indicated that the BCR repertoire of the DKO B-1a cells was drastically altered. The V-segment-encoding genes with the greatest difference in expression corresponded to Ighv12-3 and Igkv4-91, whose mRNAs were almost completely absent from DKO B-1a cells ( Fig. 2a,b) . The V H 12 and V κ 4 chains constitute a PtC-specific BCR 9 that was expressed by ~10% of peritoneal B-1 cells ( Fig. 2c,d) . Staining with anti-V H 12 or fluorochrome-loaded PtC-containing liposomes demonstrated that there were considerably fewer V H 12 + and PtC-specific B-1a cells in Bhlhe41 −/− mice than in wild-type mice, and confirmed an almost complete loss of V H 12 + cells in DKO mice ( Fig. 2c,d) . The few residual PtC-specific cells probably expressed the V H 11V κ 14 BCR, as Ighv11-2 and Igkv14-126 transcripts were detectable in DKO B-1a cells (Fig. 2b) . The 'missing' V H 12 and V κ 4 segments did not reappear in the CD5 − B-1b cell fraction (Fig. 2b,c) , which excluded the possibility that the PtC-specific cells merely lost CD5 expression. Analysis of fetal-liver chimeras ( Fig. 1f,g) and bonemarrow chimeras ( Supplementary Fig. 2f ) confirmed that the loss of V H 12 + B-1 cells in DKO mice was cell intrinsic. Hence, Bhlhe41, Igkv4-86
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Control of B-1a cell development by Bhlhe41 and Bhlhe40
To investigate the role of Bhlhe41 in B-1a cell development, we assessed the expression and function of Bhlhe41 in B-1-specified progenitor cells, which can be identified as a BCR − Lin − CD93 + CD19 + B220 neg-lo cell population at fetal, neonatal and adult sites of hematopoiesis 17 . No expression of the Bhlhe41-Cre-hCD2 reporter gene was observed in these progenitor cells in fetal and neonatal liver, neonatal and adult bone marrow, or neonatal spleen ( Fig. 3a and Supplementary Fig. 3b ). Moreover, the frequency of the B-1-specified progenitor cells was not affected by the absence of Bhlhe41 and Bhlhe40 ( Fig. 3a) . We next investigated the expression and function of Bhlhe41 in the CD93 + IgM + CD19 + B220 lo CD5 + transitional B-1a (TrB-1a) cells that can be detected in the spleen 1 week after birth 25 . Analysis of this population revealed high expression of the Bhlhe41-Cre-hCD2 reporter gene in wild-type mice and an almost complete loss of these transitional B-1a cells in DKO mice (Fig. 3b) . Hence, Bhlhe41 and Bhlhe40 were required for the generation of transitional B-1a cells.
We next investigated whether the alterations in the BCR repertoire observed in the B-1a cells of adult DKO mice might have arisen from a defect in an early selection event or a later failure of these cells to expand their populations. For this, we characterized the emergence of V H 12 + PtC-specific B-1a cells early in the ontogeny of wild-type mice. While very low numbers of V H 12 + B cells were detected in neonatal liver at day 1, these cells were not PtC specific, as judged by the lack of binding of PtC-containing liposomes (Fig. 3c) . However, small numbers of both V H 12 + PtC-specific cells and V H 12 − PtC-specific cells were detected in the spleen at postnatal day 9 ( Fig. 3d and Supplementary Fig. 3c ). The PtC-specific cells were thus scarce in neonates and underwent population expansion only in adult mice ( Fig. 3d and Supplementary Fig. 3c A r t i c l e s ontogeny. A similar number of non-PtC-specific V H 12 + B cells was present in wild-type neonatal livers and DKO neonatal livers at day 1 (Fig. 3c) , which indicated that Bhlhe41 and Bhlhe40 were dispensable for V H -DJ H recombination of the V H 12 gene segment. However, the emergence of PtC-specific V H 12 + cells in the neonatal spleen at day 9 was severely compromised in DKO mice, whereas the non-PtCspecific V H 12 + B cells were not affected (Fig. 3d) . Hence, Bhlhe41 and Bhlhe40 controlled the earliest stages of B-1a BCR repertoire selection but not Igh rearrangements, consistent with their lack of expression in pro-B cells. Fig. 4a  and Supplementary Fig. 4a ). As shown by principal-component analysis of RNA-seq data, the V H 12V κ 4-transgenic B-1a cells clustered closely together with polyclonal B-1a cells (Supplementary Fig. 4b) , which demonstrated that expression of the V H 12 and V κ 4 transgenes promoted the generation of largely normal B-1a cells. However, the V H 12V κ 4-transgenic B-1a cells on the DKO background had a severely altered cell surface phenotype, similar to that of non-transgenic DKO B-1a cells, as they failed to downregulate B220, were CD5 int and included a sizable fraction of CD23 + cells (Fig. 4a,b and Supplementary Fig. 4a ). Hence, the aberrant cell-surface phenotype of the DKO B-1a cells was not a result of the altered BCR repertoire. The V H 12-transgenic DKO mice had considerably fewer peritoneal B-1a cells than did V H 12-transgenic Bhlhe40 +/+ Bhlhe41 +/+ ('V H 12transgenic wild-type') mice (Fig. 4c) , similar to the low abundance of B-1a cells in non-transgenic DKO mice (Fig. 1c,e) . In contrast, the frequency of peritoneal B-1a cells in V H 12V κ 4-transgenic DKO mice was similar to that in V H 12V κ 4-transgenic Bhlhe40 +/+ Bhlhe41 +/+ ('V H 12V κ 4-transgenic wild-type') mice (Fig. 4c) . One possible explanation for this discrepancy could be that the substantial overproduction of B-1a cells in V H 12V κ 4-transgenic mice, even on the DKO background, might have masked the phenotype. Indeed, the additional expression of the V κ 4 transgene in V H 12-transgenic DKO mice increased the frequency of V H 12 + cells in the bone marrow approximately eightfold (Supplementary Fig. 4c) . To diminish the B-1a cell output, we reduced the frequency of V H 12V κ 4-transgenic precursor cells by generating chimeric mice via the transplantation of bone marrow from V H 12V κ 4transgenic DKO or wild-type (CD45.2 + ) mice, which was diluted 1:9 with bone marrow from non-transgenic wild-type (CD45.1 + ) mice. In this transplantation setting (called '10% chimeras'), the contribution of the V H 12V κ 4-transgenic wild-type or DKO bone marrow to the Lin − Sca-1 + c-Kit + cell compartment was close to 10%, as expected ( Fig. 4d) . In the peritoneal cavity, however, the frequency of V H 12V κ 4transgenic DKO B-1a cells was 5.5-fold lower than that of their V H 12V κ 4-transgenic wild-type counterparts (Fig. 4d) . Therefore, the generation and/or self-renewal of DKO B-1a cells was impaired in polyclonal, V H 12-transgenic and V H 12V κ 4-transgenic mice. We concluded that expression of the pre-rearranged V H 12 and V κ 4 transgenes 'rescued' neither the qualitative (surface) phenotype nor the quantitative (cell number) phenotype of DKO B-1a cells. Notably, the V H 12V κ 4-transgenic system provided us with a comparable setting for investigating the cellular and molecular mechanisms causing the observed phenotype, as it eliminated potential confounding effects of the altered BCR repertoire in the DKO mice.
Function of Bhlhe41 as a transcriptional repressor
We next investigated the molecular function of Bhlhe41 by identifying target genes regulated by Bhlhe41 in B-1a cells, by chromatinimmunoprecipitation followed by deep sequencing (ChIP-seq) and RNA-seq analysis. For this, we generated a Bhlhe41 knock-in allele (Bhlhe41 Tag ) by inserting, at the final Bhlhe41 codon, sequences encoding multiple tags, including the V5 epitope (Supplementary Fig. 5a ). 
A r t i c l e s
Notably, the B-1a cell compartment of Bhlhe41 Tag/Tag mice was indistinguishable from that of wild-type mice (Supplementary Fig. 5b) , which indicated that the inserted tag sequences did not interfere with Bhlhe41's function. We next used splenic B-1a cells of V H 12V κ 4transgenic Bhlhe41 Tag/Tag mice to obtain sufficient cell numbers for ChIP-seq analysis with anti-V5. Peak calling with a stringent P value of <10 −10 identified 5,757 Bhlhe41-binding regions, which defined 5,509 Bhlhe41 target genes in B-1a cells (data not shown). Analysis of the Bhlhe41 peak sequences with de novo motif-discovery programs identified the E-box motif CACGTG (Fig. 5a) that closely resembles the previously identified Bhlhe41-and Bhlhe40-binding motifs 38 .
Notably, most Bhlhe41 peaks (63%) were located at gene promoters ( Fig. 5b) and were present in open chromatin regions (Fig. 5c,d) , as determined by the assay for transposase-accessible chromatin (ATAC) combined with deep sequencing (ATAC-seq) 39 . To identify genes regulated by Bhlhe41 and Bhlhe40, we compared V H 12V κ 4-transgenic wild-type and DKO B-1a cells by RNA-seq. This analysis identified 168 activated genes and 151 repressed genes (Fig. 5e) , selected by a difference in expression of over twofold, an adjusted P value of <0.05 and a TPM value (transcripts per million) of >5 in one of the two cell populations. As RNA-seq was also performed with non-transgenic wild-type and DKO B-1a cells, we compared both RNA-seq data sets by gene-set-enrichment analysis (GSEA), which revealed similar gene regulation by Bhlhe41 and Bhlhe40 in V H 12V κ 4transgenic B-1a cells and polyclonal B-1a cells (Supplementary Fig. 5c ). By determining the overlap between the Bhlhe41-bound genes and Bhlhe41-regulated genes, we identified 41 potentially directly activated target genes and 90 potentially directly repressed target genes (Fig. 5d,e) . Notably, the majority (60%) of repressed genes were bound by Bhlhe41, in contrast to only 24% of the activated genes ( Fig. 5e) , which suggested that Bhlhe41 functioned predominantly as a transcriptional repressor in B-1a cells. As shown by ATAC-seq, Bhlhe41-mediated repression was not associated with a decrease in chromatin accessibility (Supplementary Fig. 5d ).
Impaired BCR signaling in V H 12V k 4-transgenic DKO B-1a cells
As B-1a cells depend on strong BCR signaling 4,5 , we next compared the phosphorylation of BCR signaling components in wild-type and DKO B-1a cells. Consistent with constitutive BCR signaling in B-1a cells 40, 41 , we noted that the phosphorylation of BCR signaling components could be readily detected in ex vivo B-1a cells without exogenous stimulation, when the cells were kept on ice before fixation. Our analysis did not reveal any reproducible signaling defects in polyclonal DKO B-1a cells (data not shown), possibly due to the selection of B-1a cells with BCRs that underwent normal BCR signaling in the absence of Bhlhe41 and Bhlhe40. In contrast, BCR signaling was impaired in V H 12V κ 4-transgenic DKO B-1a cells, which exhibited less phosphorylation of the BCR signaling components BLNK, Btk, ERK, PLCγ2 and Syk than that of V H 12V κ 4-transgenic wild-type B-1a cells (Fig. 6a) . The V H 12V κ 4-transgenic DKO B-1a cells, however, were not anergic, as they showed normal intracellular calcium signaling upon stimulation of the BCR with anti-IgM (Supplementary Fig. 6a ).
Most genes encoding core components of BCR signaling had similar expression in V H 12V κ 4-transgenic wild-type B-1a cells and V H 12V κ 4-transgenic DKO B-1a cells, except for two gene classes (Supplementary Fig. 6b) . First, the abundance of Ighm transcripts, which encode the constant region of the immunoglobulin-µ heavy chain, was 1.7-fold lower in V H 12V κ 4-transgenic DKO B-1a cells than in V H 12V κ 4-transgenic wild-type B-1a cells, which resulted in a corresponding decrease in the surface expression of IgM ( Supplementary  Fig. 6c ). Co-staining for intracellular IgM and phosphorylated epitopes of signal transducers demonstrated a correlation between expression of the V H 12V κ 4 BCR and the phosphorylation of BCR signaling components (Supplementary Fig. 6d ), which indicated that the lower IgM expression in DKO cells might have functional consequences. IgM (Ighm) expression, however, was not lower in polyclonal DKO B-1a cells than in wild-type B-1a cells (data not shown), possibly due to selection of the altered BCR repertoire of these cells. Second, the expression of genes encoding several negative regulators of BCR signaling was derepressed in both V H 12V κ 4-transgenic DKO B-1a cells and polyclonal DKO B-1a cells relative to the expression of those genes in their wild-type counterparts (Fig. 6b) . These included Lpxn, which encodes an inhibitory adaptor 42 , and Cd72, which encodes an immunoreceptor-tyrosine-based-inhibitory-motifcontaining receptor known to restrict the accumulation of B-1 cells 7 . Surface expression of CD72 was also increased on both polyclonal DKO B-1a cells and V H 12V κ 4-transgenic DKO B-1a cells relative to its expression on their wild-type counterparts (Fig. 6c) . Four genes (Dusp1, Dusp2, Dusp4 and Dusp6) that encode dual-specificity phosphatases that can dephosphorylate the kinases ERK, JNK and p38 were also derepressed in the absence of Bhlhe41 and Bhlhe40 (Fig. 6b) . Notably, all six genes were directly repressed by Bhlhe41, as shown by the presence of Bhlhe41-binding sites in their vicinity ( Figs. 5d and 6d) . Hence, the BCR signaling defects of the V H 12V κ 4transgenic DKO B-1a cells were associated with the derepression of genes encoding several negative regulators of this pathway.
As PtC-specific V H 12V κ 4 + B-1a cells were lost in the DKO mice, we next investigated whether these B-1a cells were particularly sensitive to defective BCR signaling. For this, we analyzed PtC-specific B-1a cells in Cd19 −/− mice, which have considerably fewer B-1a cells due to the lack of the co-stimulatory receptor CD19 (ref. 43) . While the residual B-1a cell population in the peritoneal cavity of Cd19 −/− mice still included some PtC-specific cells, it contained only very few V H 12 + cells ( Fig. 6e  and Supplementary Fig. 6e) , similar to the observation made with Bhlhe40 −/− Bhlhe41 −/− mice (Fig. 2c,d) . Hence, the V H 12V κ 4 + B-1a cells seemed to be particularly sensitive to impaired BCR signaling.
Restriction of B-1a cell proliferation by Bhlhe41 and Bhlhe40
As the number of B-1a cells was much lower in DKO mice than in wild-type mice, we investigated whether proliferation was affected by loss of Bhlhe41 and Bhlhe40. Most wild-type and V H 12V κ 4-transgenic B-1a cells exhibited low expression of the proliferation marker Ki67 (Fig. 7a-c) , consistent with their slow proliferation at steady state 2,3 . Unexpectedly, DKO B-1a cell populations in both the polyclonal setting and the V H 12V κ 4-transgenic setting exhibited a threefold increase in Ki67 hi cells and in cells in the S, G2 or M phase of the cell cycle relative to the abundance of such cells in their wild-type counterparts (Fig. 7a-c) . Moreover, the same phenotype was evident in mixed-fetal-liver chimeras generated with non-transgenic wildtype and DKO cells (Fig. 7d) . Hence, the increased proliferation was a cell-autonomous property of the DKO B-1a cells.
Several genes encoding known or putative cell-cycle regulators were identified as repressed Bhlhe41 target genes, as they had higher expression in DKO B-1a cells than in wild-type B-1a cells and were bound by Bhlhe41 in wild-type B-1a cells (Fig. 7e,f and Supplementary Fig. 7a,b) . Six of these genes encoded the following proteins: cyclin H (Ccnh); a cyclin-dependent kinase-like protein (Cdkl1); a regulatory subunit of cyclin-dependent kinases (Cks2); two helicases linked to DNA replication (Hells and Recql5); and a deubiquitinase involved in the G2 DNA-damage checkpoint (Usp28) (Supplementary Fig. 7a,b) . Notably, the expression of four genes (E2f1, E2f2, E2f7 and E2f8) encoding members of the E2F family of cell-cycle-regulating transcription factors was also higher in DKO B-1a cells than in wild-type B-1a cells (Fig. 7e) , and Bhlhe41 binding was observed at E2f1, E2f7 and E2f8 (Figs. 5d and 7f) , which suggested that they were directly repressed by Bhlhe41. If Bhlhe41 and Bhlhe40 restricted B-1a cell proliferation by downregulating the expression of E2F transcription factors, E2F target genes would likewise be upregulated in DKO B-1a cells. Indeed, GSEA revealed substantial derepression of E2F target genes in DKO B-1a cells relative to their expression in wild-type B-1a cells (Fig. 7g) . We concluded, therefore, that Bhlhe41, together with Bhlhe40, enforced the slow proliferation of B-1a lymphocytes, at least in part by direct repression of genes encoding cell-cycle regulators, including E2F transcription factors.
Control of B-1a cell self-renewal by Bhlhe41 and Bhlhe40
As DKO B-1a cells exhibited increased proliferation ( Fig. 7a-d ) despite their lower numbers (Fig. 1d,e ), we next investigated whether a defect in survival might have contributed to this phenotype. Indeed, ex vivo analysis of V H 12V κ 4-transgenic DKO B-1a cells revealed a fourfold increase in cell death relative to that of V H 12V κ 4-transgenic wild-type B-1a cells (Fig. 8a) . A similar increase in cell death was, however, not evident in non-transgenic DKO mice (data not shown), possibly due to the selection of cells with less sensitivity to the deficiency in Bhlhe41 and Bhlhe40. To investigate whether homeostasis of the polyclonal B-1a cells might nevertheless be affected by the loss of Bhlhe41 and Bhlhe40, we sorted peritoneal B-1a cells from wild-type or DKO (CD45.2 + ) mice and transferred them intraperitoneally into sublethally irradiated wild-type (CD45.1 + ) recipient mice. The DKO B-1a cells failed to maintain their numbers and disappeared from the recipients with relatively slow kinetics after 2 months, in contrast to the wild-type B-1a cells (Fig. 8b) . In line with that failure to selfrenew, the peritoneal B-1a cells in DKO mice did not accumulate with age, as the absolute number of these cells remained largely unchanged between 1 month and 4 months of age, while the number of wildtype B-1a cells increased significantly (Fig. 8c) . Consistent with the inability to generate PtC-specific V H 12 + B-1a cells in early ontogeny, a substantial decrease in V H 12 + B-1a cells was also evident in young DKO mice relative to the abundance of those cells in wild-type mice of the same age (Fig. 8d ). Together these results indicated that Bhlhe41 and Bhlhe40 regulated the self-renewal of B-1a cells.
We next investigated our RNA-seq data for possible mediators of the pro-survival function of Bhlhe41 and Bhlhe40. Tnfrsf13b and Tnfrsf13c, which encode receptors that regulate B cell survival (TACI A r t i c l e s and BAFF-R, respectively), exhibited similar expression in wild-type B-1a cells and DKO B-1a cells (Supplementary Fig. 8a) . In contrast, expression of Il5ra (which encodes the cytokine receptor subunit IL-5Rα) and surface expression of IL-5Rα were considerably reduced, in a cell-intrinsic manner, in both V H 12V κ 4-transgenic DKO B-1a cells and polyclonal DKO B-1a cells relative to the expression in their wild-type counterparts (Fig. 8e,f and Supplementary Fig. 8b) . B-1a cells are known to depend on signaling via the IL-5 receptor, 
as their numbers are decreased in Il5ra −/− mice 44, 45 , albeit to a lesser extent than in Bhlhe40 −/− Bhlhe41 −/− mice. We next incubated sorted V H 12V κ 4-transgenic B-1a cells with or without IL-5. While IL-5 enhanced the survival of wild-type B-1a lymphocytes in vitro, it had no effect on DKO B-1a cells (Fig. 8g) . We concluded, therefore, that the residual IL-5R expression was insufficient to mediate the pro-survival function of IL-5 in DKO B-1a cells.
The IL-5 receptor belongs to the family of receptors for the cytokines IL-3, IL-5 and GM-CSF that share the same β-chain (encoded by Csf2rb), except for the IL-3 receptor, which can also utilize a related β-chain (encoded by Csf2rb2). Notably, the expression of four genes (Il5ra, Il3ra, Csf2rb, Csf2rb2) encoding the αand β-chains of this family was downregulated in DKO B-1a cells relative to their expression in wild-type B-1a cells (Fig. 8e) . That result was confirmed by the observed decrease in surface expression of IL-3Rα on DKO B-1a cells ( Fig. 8f and Supplementary Fig. 8b) . No binding of Bhlhe41 was detected in the vicinity of these four Bhlhe41-activated genes (data not shown), consistent with a primary role for Bhlhe41 in transcriptional repression. Notably, Csf2rb −/− Csf2rb2 −/− mice, which are unable to respond to IL-5, IL-3 or GM-CSF 46 , exhibited a decrease in the number of B-1a cells relative to that in wild-type mice, which was, however, less than that observed in Bhlhe40 −/− Bhlhe41 −/− mice (Fig. 8h) . The frequency of V H 12 + B-1a cells was not affected in Csf2rb −/− Csf2rb2 −/− mice, in contrast to the frequency of those cells in Bhlhe40 −/− Bhlhe41 −/− mice (Fig. 8h) . Moreover, only old Csf2rb −/− Csf2rb2 −/− mice exhibited the mutant phenotype (data not shown), a result that was consistent with a self-renewal defect. These data therefore demonstrated that Bhlhe41 and Bhlhe40 controlled the self-renewal of B-1a cells in part by rendering B-1a cells receptive to pro-survival cytokine signaling.
DISCUSSION
Here we have identified an essential role for the transcription factor Bhlhe41, with a lesser contribution by Bhlhe40, in the control of several key aspects of B-1a cell biology. First, we identified transitional B-1a cells 25 in the neonatal spleen as the earliest developmental stage exhibiting high Bhlhe41 expression. Consistent with that finding, these transitional B-1a cells were largely lost in the absence of Bhlhe41 and Bhlhe40, which indicated that these transcription factors are required for B-1a cell development. Second, while wild-type B-1a cells had a restricted BCR repertoire with several dominant specificities, the DKO B-1a cells had a drastically altered V-segment usage, which demonstrated that Bhlhe41, together with Bhlhe40, shapes the BCR repertoire of B-1a cells. Finally, in contrast to wild-type B-1a cells, which were capable of life-long survival accompanied by slow proliferation, DKO B-1a cells were decreased in number, exhibited aberrantly enhanced proliferation combined with increased cell death and failed to accumulate with age, which indicated that Bhlhe41 and Bhlhe40 control the self-renewal of B-1a cells.
The altered BCR repertoire of DKO B-1a cells suggested that the residual cells were selected for diminished sensitivity to the deficiency in Bhlhe41 and Bhlhe40, which might mask some aspects of the mutant phenotype of DKO cells. To avoid such confounding effects, we assessed the DKO phenotype in both polyclonal B-1a cells and V H 12V κ 4transgenic B-1a cells. Most aspects of the mutant phenotype were apparent in both settings. This included a substantial decrease in B-1a cells, an altered cell-surface phenotype, increased cell proliferation, upregulated expression of positive cell-cycle regulators, augmented expression of negative regulators of BCR signaling and downregulation of the receptors for IL-5 and IL-3 in both DKO B-1a cell types. While a survival defect was more obvious for V H 12V κ 4-transgenic DKO B-1a cells, polyclonal DKO B-1a cells failed to accumulate with age and, unlike their wild-type counterparts, disappeared from the recipients after adoptive transfer. Given the increased proliferation of DKO cells, these observations point to a survival defect, albeit less acute than that observed for V H 12V κ 4-transgenic DKO mice. However, one aspect of the DKO phenotype, defective BCR signaling, was evident only in V H 12V κ 4-transgenic B-1a cells. One possible explanation for this discrepancy could be that the DKO B-1a cells expressing BCR specificities with diminished signaling potential underwent cell death and thus counter-selection during postnatal development, which resulted in viable DKO B-1a cells with normal BCR signaling in the adult mice analyzed. In contrast, V H 12V κ 4transgenic B-1a cells seem to be constantly generated during adult life 47 ; hence, the V H 12V κ 4-transgenic DKO B-1a cells with their attenuated BCR signaling were present at the time of analysis.
The PtC-specific V H 12V κ 4 BCR is almost completely lost from the repertoire of DKO B-1a cells, possibly due to its impaired signaling in the absence of Bhlhe41 and Bhlh40. Here we demonstrated that the V H 12V κ 4-expressing B-1a cells were particularly sensitive to defective BCR signaling, as indicated by their loss from the BCR repertoire of Cd19 −/− mice. Notably, mice deficient in the signal transducer RasGRP1 also show a selective decrease in PtC-specific B-1a cells 48 . While Bhlhe41 did not regulate Cd19 or Rasgrp1, it directly repressed multiple genes encoding negative regulators of BCR signaling, including several dual-specificity phosphatases and the receptor CD72, which is known to restrict the number of B-1 cells 7 . The increased expression of these negative regulators in V H 12V κ 4-transgenic DKO B-1a cells might have contributed to the observed decrease in phosphorylation of BCR signal transducers. This signaling defect probably contributes to both the general decrease in the number of B-1a cells and the selective loss of B-1a cells with certain BCR specificities.
Signaling via the IL-5 receptor has been linked to the self-renewal of B-1a cells 44, 45 . Here we have demonstrated that Bhlhe41 and Bhlhe40 were required for the expression of both α-chains (Il5ra and Il3ra) and β-chains (Csf2rb and Csf2rb2) of the family of receptors for IL-5, IL-3 and GM-CSF. IL-5Rα expression was fivefold lower in DKO B-1a cells than in wild-type B-1a cells, and this low expression was insufficient to mediate cell survival even when high concentrations of IL-5 were used for in vitro culture. Moreover, Csf2rb −/− Csf2rb2 −/− mice had fewer B-1a cells, which provides additional in vivo evidence of a function for this cytokine receptor family in B-1a cells. A decrease in the number of B-1a cells was obvious only in old Csf2rb −/− Csf2rb2 −/− mice, indicative of a role for the encoded receptor β-chains in the self-renewal of B-1a cells, in agreement with the age dependence of the respective mutant phenotype of Bhlhe40 −/− Bhlhe41 −/− mice.
B-1a cells, like adult tissue stem cells, undergo self-renewal associated with slow cell proliferation. Consistent with the published characterization of Bhlhe40 as a cytostatic factor in B cells overexpressing this regulator 36, 49 , we have now identified Bhlhe41 and Bhlhe40 as negative regulators of the cell cycle, as DKO B-1a cells were more proliferative than their wild-type counterparts. Mechanistically, this could be explained by the direct Bhlhe41-mediated repression of multiple genes encoding components of the cell-cycle machinery, including three E2F transcription factors. Paradoxically, the accelerated proliferation of the DKO B-1a cells was associated with increased cell death. We therefore speculate that the increase in apoptosis might be in part a consequence of the unleashed proliferation, as ectopic activation of the cell-cycle machinery can be a potent inducer of cell death 50 .
The various aspects of the mutant phenotype of Bhlhe40 −/− Bhlhe41 −/− mice were caused by distinct mechanisms. First, while the impaired A r t i c l e s self-renewal of DKO B-1a cells became more apparent with age, the 'preferential' loss of V H 12 + B-1a cells was already observed in the neonatal spleen of DKO mice. Hence, the self-renewal defect must be independent of the BCR repertoire change. Second, the reduced expression of receptors for IL-5 and IL-3 probably did not result from impaired BCR signaling, as the residual B-1a cells in CD19-deficient mice exhibited normal IL-5α expression (data not shown). Finally, the increased proliferation of DKO B-1a cells indicated yet another aspect of the Bhlhe41-regulated molecular program, as Bhlhe41 directly repressed genes encoding positive cell-cycle regulators. Thus, the increased proliferation of DKO B-1a cells seems to be independent of both the reduced BCR signaling and impaired cytokine-receptor expression. Bhlhe41 thus executes pleiotropic functions in B-1a cells by controlling distinct aspects of B-1a cell physiology.
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